Trump's Deal Slashes Prices on New Weight Loss Pills
Mesa News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
President Trumps deal with Eli Lilly and Novo Nordisk brings affordable weight loss drugs to market. Eli Lillys Foundayo, a once-daily GLP-1 med, starts shipping Monday, with insured folks possibly paying just $25 a month. Novo Nordisks Wegovy, already popular, also uses GLP-1 technology. These drugs, originally for diabetes, now target weight loss, curbing appetite and boosting fullness signals. Medicare and private plans may cover them, potentially reshaping obesity care.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/94840a0059758f9d